Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study.

By Ramachandran S. Vasan, Martin G. Larson, E. Leip, W. Kannel, Daniel Levy. The Lancet, 2001

1,122 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

European guidelines on cardiovascular disease prevention in clinical practice: executive summary. (2007, neutral): “2-fold increase in relative risk from CVD compared with those with BP levels below 120/80 mmHg.(97) The classification of hypertension used in the 2003 and 2007 ESH/ESC guidelines has been retained (Table 4).”
Factors Influencing the Decline in Stroke Mortality (2013, background): “The percentage of patients with hypertension receiving treatment has increased to the point where >90% of the population know the relationship between HBP and stroke, nearly 70% of the adult hypertensive population are receiving treatment, and 46% of those treated have their blood pressure controlle”
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit (2007, neutral): “2-fold increase in relative risk from CVD compared with those with BP levels below 120/80 mmHg.(97) The classification of hypertension used in the 2003 and 2007 ESH/ESC guidelines has been retained (Table 4).”